Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bivalirudin Plus Prasugrel vs Abciximab Plus Clopidogrel in STEMI
NCT01158846Phase 4Unknown
- Sponsor
- IRCCS Ospedale Galeazzi-Sant'Ambrogio
- Start
- Aug 2010
- Primary completion
- Jun 2011
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of prasugrel and bivalirudin in ST elevation myocardial infarction (STEMI) (2 arms), sponsored by IRCCS Ospedale Galeazzi-Sant'Ambrogio. Primary endpoint: Major Adverse Cardiovascular Events at 1 year. Status: unknown.
02
Drugs
prasugrelbivalirudin
03
Conditions
ST elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on NCT01158846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158846.